Client News

Formycon Joins the SDAX of the German Stock Exchange

Medigene AG Expands Patent Portfolio with Patent Grant for its MAGE-A4 Targeted T Cell Receptor in China

Leon-Nanodrugs: Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery

Medigene AG Receives Milestone Payment from Regeneron Pharmaceuticals, Inc.

Mainz Biomed Announces Stock Split

Formycon Reports Nine-Month Results for 2024 and Continues Growth Trajectory with Further Operational Success

Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment

Pentixapharm Holding AG: First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab